ProfileGDS5822 / ILMN_3073395
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 67% 60% 48% 61% 41% 27% 44% 41% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 139.567
GSM1276600PDAC Late Ablation Control 231.260
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 118.648
GSM1276603PDAC Late Ablation 232.161
GSM1276604PDAC Late Ablation 319.941
GSM1303940PDAC Late Ablation_anti-CTLA4 114.727
GSM1303941PDAC Late Ablation_anti-CTLA4 221.544
GSM1303942PDAC Late Ablation_anti-CTLA4 319.741